Study of the immune reactions of the humoral and cellular types in rats, which had suffered terminal condition, has demonstrated the development of sensitization. The degree of the immunological shifts was determined by clinical death duration and by the period of postresuscitation. Injection of piracetam (100 mg/kg, subcutaneously) within the first 10 days after resuscitation noticeably reduced the manifestations of neurosensitization.